Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
New research has identified hundreds of proteins that can lead to the development of metabolic diseases, such as type 2 diabetes mellitus, and therefore have treatment potential.
Read Full NewsTest your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on diagnosing parasomnias!
Late-breaking data from the 2026 ACTRIMS Forum showed that bazedoxifene acetate failed to improve remyelination outcomes in midlife women with relapsing MS, despite a favorable safety profile.
A nurse practitioner at the Rocky Mountain MS Clinic discussed emerging therapeutics, evolving management strategies, and unmet needs in multiple sclerosis, specifically in women’s health.
The FDA has granted priority review to Takeda’s new drug application for oveporexton, an orexin receptor 2-selective agonist, for narcolepsy type 1, with a PDUFA date in the third quarter of 2026.
Paul Nghiem highlights several key takeaways from his talk on cutaneous oncology, touching on various advances in skin cancer management.
VALIANT: Verekitug Reduces Average Annual Asthma Flare-Ups in Phase 2 Trial
REZOLVE-AD: Rezpegaldesleukin Improves Symptoms of Atopic Dermatitis
1.
Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.
2.
Surviving cancer, still suffering: Survey reveals gaps in follow‑up care
3.
FDA Approves First Menin Inhibitor for Acute Leukemia
4.
Charles III, King of Kings, is Cancerous.
5.
Obesity-related cancers are more likely in people who are obese in both healthy and unhealthy ways.
1.
From Bench to Bedside: The New Era of Lymphoma Treatment and Education
2.
The Unfolding Revolution of Precision Medicine, Immunotherapy, and Digital Transformation in Medical Oncology 2025
3.
What Is Carboxyhemoglobin And How Can It Affect Your Health?
4.
The Pivotal Role of Telomerase in Breast Cancer Therapy Resistance and Treatment Strategies
5.
Understanding Neutropenic Fever: What It Is and Why it's a Serious Concern
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
3.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
4.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
5.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge